Your browser doesn't support javascript.
loading
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
Mandorfer, M; Kozbial, K; Freissmuth, C; Schwabl, P; Stättermayer, A F; Reiberger, T; Beinhardt, S; Schwarzer, R; Trauner, M; Ferlitsch, A; Hofer, H; Peck-Radosavljevic, M; Ferenci, P.
Affiliation
  • Mandorfer M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kozbial K; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Freissmuth C; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Schwabl P; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Stättermayer AF; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Reiberger T; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Beinhardt S; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Schwarzer R; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Trauner M; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Ferlitsch A; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Hofer H; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Ferenci P; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Aliment Pharmacol Ther ; 42(6): 707-18, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26179884
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Portal Pressure / Hepatitis C, Chronic / Hypertension, Portal / Liver Cirrhosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Affiliation country: Austria Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Portal Pressure / Hepatitis C, Chronic / Hypertension, Portal / Liver Cirrhosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Affiliation country: Austria Country of publication: United kingdom